NCCTG N0821 (Alliance): A phase II first-line study of pemetrexed, carboplatin and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer with good performance status

PURPOSE: We hypothesized that the combination of bevacizumab, carboplatin and pemetrexed will be an effective first-line regimen in fit, elderly patients with nonsquamous NSCLC. PATIENTS AND METHODS: Treatment-naïve, stage IIIB/IV nonsquamous NSCLC patients ≥ 70 years old with good performance statu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dy, Grace K., Molina, Julian R., Qi, Yingwei, Ansari, Rafat, Thomas, Sachdev, Ross, Helen J., Soori, Gamini, Anderson, Daniel, Aubry, Marie Christine, Meyers, Jeffrey, Adjei, Araba A., Mandrekar, Sumithra, Adjei, Alex A.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145612/
https://ncbi.nlm.nih.gov/pubmed/25157767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000217
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items